ConductScience.org, home

Paper8552591

Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers.

Chang K and 1 other. Proc Natl Acad Sci U S A, 1996. Cited by 631 papers, by iCite.

Cite this record

ConductScience Library. Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers. Papers, record 8552591. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8552591

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers.
PubMed
Journal
Proc Natl Acad Sci U S A
PubMed
Year
1996
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
631
iCite
Relative citation ratio, by iCite
13.9
iCite
Revised in PubMed
2022-03-21
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chang KK
2Pastan II

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, NeoplasmMajor topic
Membrane GlycoproteinsMajor topic
Ovarian NeoplasmsMajor topic
Amino Acid Sequence
Base Sequence
Cell Adhesion Molecules
Cloning, Molecular
DNA, Complementary
Female
GPI-Linked Proteins
Gene Expression
Genes
Glycosylphosphatidylinositols
HeLa Cells
Humans
Mesothelin
Molecular Sequence Data
RNA, Messenger

Source PubMed

Download CSV of topics

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT01051934A Phase I Trial of SS1 (dsFv) PE38 With Paclitaxel, Carboplatin, and Bevacizumab in Subjects With Unresectable Non-Small Cell Lung AdenocarcinomaBackgroundClinicalTrials.gov
NCT01445392SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural MesotheliomaBackgroundClinicalTrials.gov

Download CSV of trials

References18

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1271968DNA sequencing with chain-terminating inhibitors.Proc Natl Acad Sci U S A1977https://conductscience.org/library/papers/271968PubMed
26310399A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.N Engl J Med1983https://conductscience.org/library/papers/6310399PubMed
32953793
Removal of lymphocyte surface molecules with phosphatidylinositol-specific phospholipase C: effects on mitogen responses and evidence that ThB and certain Qa antigens are membrane-anchored via phosphatidylinositol.
J Immunol1987https://conductscience.org/library/papers/2953793PubMed
43670292High-efficiency transformation of mammalian cells by plasmid DNA.Mol Cell Biol1987https://conductscience.org/library/papers/3670292PubMed
53313053Anchoring mechanisms for LFA-3 cell adhesion glycoprotein at membrane surface.Nature1987https://conductscience.org/library/papers/3313053PubMed
63313277An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs.Nucleic Acids Res1987https://conductscience.org/library/papers/3313277PubMed
72152774Evaluation of ricin A chain-containing immunotoxins directed against the CD30 antigen as potential reagents for the treatment of Hodgkin's disease.Cancer Res1990https://conductscience.org/library/papers/2152774PubMed
81717147Folate-binding protein is a marker for ovarian cancer.Cancer Res1991https://conductscience.org/library/papers/1717147PubMed
91719635GPI-anchored cell-surface molecules complexed to protein tyrosine kinases.Science1991https://conductscience.org/library/papers/1719635PubMed
101727378Characterization of the antigen (CAK1) recognized by monoclonal antibody K1 present on ovarian cancers and normal mesothelium.Cancer Res1992https://conductscience.org/library/papers/1727378PubMed
111755986Imaging and therapy with monoclonal antibodies in non-hematopoietic tumors.Curr Opin Immunol1991https://conductscience.org/library/papers/1755986PubMed
121735605Isolation and characterization of a monoclonal antibody, K1, reactive with ovarian cancers and normal mesothelium.Int J Cancer1992https://conductscience.org/library/papers/1735605PubMed
131599018Monoclonal antibody K1 reacts with epithelial mesothelioma but not with lung adenocarcinoma.Am J Surg Pathol1992https://conductscience.org/library/papers/1599018PubMed
141351045Frequent expression of the tumor antigen CAK1 in squamous-cell carcinomas.Int J Cancer1992https://conductscience.org/library/papers/1351045PubMed
151498329Monoclonal antibody-based therapies of leukemia and lymphoma.Blood1992https://conductscience.org/library/papers/1498329PubMed
168150545Molecular cloning and expression of a cDNA encoding a protein detected by the K1 antibody from an ovarian carcinoma (OVCAR-3) cell line.Int J Cancer1994https://conductscience.org/library/papers/8150545PubMed
178027078Cleavage of pseudomonas exotoxin and diphtheria toxin by a furin-like enzyme prepared from beef liver.J Biol Chem1994https://conductscience.org/library/papers/8027078PubMed
187536959Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-alpha-induced angiogenesis.Science1995https://conductscience.org/library/papers/7536959PubMed

Download CSV of references

Cited by368

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 631 citations.

PMIDTitleJournalYearIn PapersSource
42920992Epitope selection overcomes antigen shedding to enable effective CAR-M therapy in solid tumors.Mol Ther Oncol2026https://conductscience.org/library/papers/42920992PubMed
42608511Cold and hot tumors: immunological determinants, cancer-immunity cycle dysregulation, and nanotechnology-driven therapeutic approaches.Mol Biomed2026https://conductscience.org/library/papers/42608511PubMed
42591971Conformational epitope engagement by anti-MSLN ADC RC88 confers resistance to soluble mesothelin.Antib Ther2026https://conductscience.org/library/papers/42591971PubMed
42483566Near Infrared Photoimmunotherapy for Lung Cancer: Recent Development and Perspective.Immunotargets Ther2026https://conductscience.org/library/papers/42483566PubMed
42459653Engineering a juxtamembrane-targeting CAR T-cell against mesothelin: a novel binder resilient to shed antigen for enhanced efficacy against ovarian and pancreatic cancer.Front Immunol2026https://conductscience.org/library/papers/42459653PubMed
42292493Evaluating mesothelin as an immunotherapeutic target for endogenous T cells.Front Immunol2026https://conductscience.org/library/papers/42292493PubMed
42279275The Role of Mesothelin in Gynecological Tumors and Its Significance in Targeted Therapies-A Review.Cancers (Basel)2026https://conductscience.org/library/papers/42279275PubMed
42125244Mesothelin-Binding Peptide Inhibits Cell Migration and Enables Targeted Delivery of a Mitochondrial-Membrane-Damaging Peptide to Pancreatic Tumors.Biomater Res2026https://conductscience.org/library/papers/42125244PubMed
42106231Prognostic Significance of Inflammatory, Cellular, and Tumor-Specific Biomarkers in Patients With Pleural and Peritoneal Mesothelioma.Clin Lung Cancer2026https://conductscience.org/library/papers/42106231PubMed
42035221Generation of functional mesothelial cells from human iPSCs that restore peritoneal integrity in experimental peritoneal injury.Stem Cell Res Ther2026https://conductscience.org/library/papers/42035221PubMed
41994562Mesothelin biology and the evolving landscape of targeted immunotherapy.Mol Ther Oncol2026https://conductscience.org/library/papers/41994562PubMed
41901346Radioimmunotherapy for Malignant Mesothelioma Targeting C-ERC/Mesothelin.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/41901346PubMed
41866035Mesothelin promotes acute myeloid leukemia progression through LYN-dependent signaling.J Biol Chem2026https://conductscience.org/library/papers/41866035PubMed
41824794MSLN expression predicts a high risk of EMD in AML by promoting cell adhesion and metastasis via interaction with MUC16.Blood Adv2026https://conductscience.org/library/papers/41824794PubMed
41550974RO4, a high-affinity humanized antibody against the juxtamembrane region of mesothelin for targeted cancer therapy.Antib Ther2026https://conductscience.org/library/papers/41550974PubMed
41543488Preclinical development of mesothelin-targeting CAR T cells for the treatment of cholangiocarcinoma.Hepatol Commun2026https://conductscience.org/library/papers/41543488PubMed
41513618MSLN-mediated activation of EGFR-ERK1/2 signaling drives liver metastasis in breast cancer.Cell Death Discov2026https://conductscience.org/library/papers/41513618PubMed
41400642Novel perspectives on MSLN-targeted cancer therapy: from molecular mechanisms to clinical translation.Cancer Biol Ther2025https://conductscience.org/library/papers/41400642PubMed
41335396Decoding the role of mesothelin in tumor dynamics and targeted treatment innovations.Mol Biomed2025https://conductscience.org/library/papers/41335396PubMed
41298776Comprehensive single-cell transcriptome landscape of metastatic colorectal cancer identifies budding-potential cells and their interactions with cancer-associated fibroblasts.NPJ Precis Oncol2025https://conductscience.org/library/papers/41298776PubMed

See all 368 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
MSLN10232Swiss-Prot's referenceshttps://conductscience.org/library/genes/10232

Source NCBI Gene

Download CSV of genes

Data1

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccession
GENBANKU40434

Source GENBANK

Download CSV of data

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Drugs

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8552591

GET https://conductscience.org/api/papers/v1/8552591/cited_by?page=2